Cargando…
Stem cell therapy in pain medicine
Stem cells are attracting attention as a key element in future medicine, satisfying the desire to live a healthier life with the possibility that they can regenerate tissue damaged or degenerated by disease or aging. Stem cells are defined as undifferentiated cells that have the ability to replicate...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Pain Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813895/ https://www.ncbi.nlm.nih.gov/pubmed/31569916 http://dx.doi.org/10.3344/kjp.2019.32.4.245 |
_version_ | 1783462919205289984 |
---|---|
author | Han, Yong Hee Kim, Kyung Hoon Abdi, Salahadin Kim, Tae Kyun |
author_facet | Han, Yong Hee Kim, Kyung Hoon Abdi, Salahadin Kim, Tae Kyun |
author_sort | Han, Yong Hee |
collection | PubMed |
description | Stem cells are attracting attention as a key element in future medicine, satisfying the desire to live a healthier life with the possibility that they can regenerate tissue damaged or degenerated by disease or aging. Stem cells are defined as undifferentiated cells that have the ability to replicate and differentiate themselves into various tissues cells. Stem cells, commonly encountered in clinical or preclinical stages, are largely classified into embryonic, adult, and induced pluripotent stem cells. Recently, stem cell transplantation has been frequently applied to the treatment of pain as an alternative or promising approach for the treatment of severe osteoarthritis, neuropathic pain, and intractable musculoskeletal pain which do not respond to conventional medicine. The main idea of applying stem cells to neuropathic pain is based on the ability of stem cells to release neurotrophic factors, along with providing a cellular source for replacing the injured neural cells, making them ideal candidates for modulating and possibly reversing intractable neuropathic pain. Even though various differentiation capacities of stem cells are reported, there is not enough knowledge and technique to control the differentiation into desired tissues in vivo. Even though the use of stem cells is still in the very early stages of clinical use and raises complicated ethical problems, the future of stem cells therapies is very bright with the help of accumulating evidence and technology. |
format | Online Article Text |
id | pubmed-6813895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Korean Pain Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-68138952019-10-30 Stem cell therapy in pain medicine Han, Yong Hee Kim, Kyung Hoon Abdi, Salahadin Kim, Tae Kyun Korean J Pain Review Article Stem cells are attracting attention as a key element in future medicine, satisfying the desire to live a healthier life with the possibility that they can regenerate tissue damaged or degenerated by disease or aging. Stem cells are defined as undifferentiated cells that have the ability to replicate and differentiate themselves into various tissues cells. Stem cells, commonly encountered in clinical or preclinical stages, are largely classified into embryonic, adult, and induced pluripotent stem cells. Recently, stem cell transplantation has been frequently applied to the treatment of pain as an alternative or promising approach for the treatment of severe osteoarthritis, neuropathic pain, and intractable musculoskeletal pain which do not respond to conventional medicine. The main idea of applying stem cells to neuropathic pain is based on the ability of stem cells to release neurotrophic factors, along with providing a cellular source for replacing the injured neural cells, making them ideal candidates for modulating and possibly reversing intractable neuropathic pain. Even though various differentiation capacities of stem cells are reported, there is not enough knowledge and technique to control the differentiation into desired tissues in vivo. Even though the use of stem cells is still in the very early stages of clinical use and raises complicated ethical problems, the future of stem cells therapies is very bright with the help of accumulating evidence and technology. The Korean Pain Society 2019-10 2019-10-01 /pmc/articles/PMC6813895/ /pubmed/31569916 http://dx.doi.org/10.3344/kjp.2019.32.4.245 Text en © The Korean Pain Society, 2019 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Han, Yong Hee Kim, Kyung Hoon Abdi, Salahadin Kim, Tae Kyun Stem cell therapy in pain medicine |
title | Stem cell therapy in pain medicine |
title_full | Stem cell therapy in pain medicine |
title_fullStr | Stem cell therapy in pain medicine |
title_full_unstemmed | Stem cell therapy in pain medicine |
title_short | Stem cell therapy in pain medicine |
title_sort | stem cell therapy in pain medicine |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813895/ https://www.ncbi.nlm.nih.gov/pubmed/31569916 http://dx.doi.org/10.3344/kjp.2019.32.4.245 |
work_keys_str_mv | AT hanyonghee stemcelltherapyinpainmedicine AT kimkyunghoon stemcelltherapyinpainmedicine AT abdisalahadin stemcelltherapyinpainmedicine AT kimtaekyun stemcelltherapyinpainmedicine |